The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Targeting mammalian target of rapamycin (mTOR) for health and diseases
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Insulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326
Shapiro, A. M. J., Lakey, J. R. T., Ryan, E. A., Korbutt, G. S., Toth, E., Warnock, G. L., Kneteman, N. M., & Rajotte, R. V. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007273430401 · Cited by 5,237
TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083
Kim, D.-H., Sarbassov, D. D., Ali, S. M., King, J. E., Latek, R. R., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2002) · Cell · doi:10.1016/s0092-8674(02)00808-5 · Cited by 2,986
Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism
Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C. J., Squitieri, F., Ibanez, P., Joosse, M., et al. (2003) · Science · doi:10.1126/science.1077209 · Cited by 2,778
Anderson, E. N. (1977) · eScholarship (California Digital Library) · Cited by 2,567
Autophagy in Health and Disease: A Double-Edged Sword
Shintani, T., & Klionsky, D. J. (2004) · Science · doi:10.1126/science.1099993 · Cited by 2,534
Nonoperative Dilatation of Coronary-Artery Stenosis: Percutaneous Transluminal Coronary Angioplasty
Grüntzig, A. R., Senning, Å., & Siegenthaler, W. E. (1979) · New England Journal of Medicine · doi:10.1056/nejm197907123010201 · Cited by 2,419
Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB
Sarbassov, D. D., Ali, S. M., Sengupta, S., Sheen, J.-H., Hsu, P. P., Bagley, A. F., Markhard, A. L., & Sabatini, D. M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.029 · Cited by 2,365
Ravikumar, B., Vacher, C., Berger, Z., Davies, J. E., Luo, S., Oroz, L. G., Scaravilli, F., Easton, D. F., Duden, R., O'Kane, C. J., et al. (2004) · Nature Genetics · doi:10.1038/ng1362 · Cited by 2,347
IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice
Holzenberger, M., Dupont, J., Ducos, B., Leneuve, P., Géloën, A., Even, P. C., Cervera, P., & Le Bouc, Y. (2003) · Nature · doi:10.1038/nature01298 · Cited by 2,109
Discovering High-Affinity Ligands for Proteins: SAR by NMR
Shuker, S. B., Hajduk, P. J., Meadows, R. P., & Fesik, S. W. (1996) · Science · doi:10.1126/science.274.5292.1531 · Cited by 2,041
Guba, M., von Breitenbuch, P., Steinbauer, M., Koehl, G., Flegel, S., Hornung, M., Bruns, C. J., Zuelke, C., Farkas, S., Anthuber, M., et al. (2002) · Nature Medicine · doi:10.1038/nm0202-128 · Cited by 1,739
Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity
Um, S. H., Frigerio, F., Watanabe, M., Picard, F., Joaquin, M., Sticker, M., Fumagalli, S., Allegrini, P. R., Kozma, S. C., Auwerx, J., et al. (2004) · Nature · doi:10.1038/nature02866 · Cited by 1,677
Lin, K., Dorman, J. B., Rodan, A., & Kenyon, C. (1997) · Science · doi:10.1126/science.278.5341.1319 · Cited by 1,495
Brugarolas, J., Lei, K., Hurley, R. L., Manning, B. D., Reiling, J. H., Hafen, E., Witters, L. A., Ellisen, L. W., & Kaelin, W. G. (2004) · Genes & Development · doi:10.1101/gad.1256804 · Cited by 1,384
Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway
Kapahi, P., Zid, B. M., Harper, T., Koslover, D., Sapin, V., & Benzer, S. (2004) · Current Biology · doi:10.1016/j.cub.2004.03.059 · Cited by 1,293
Regulation of Yeast Replicative Life Span by TOR and Sch9 in Response to Nutrients
Kaeberlein, M., Powers, R. W., Steffen, K. K., Westman, E. A., Hu, D., Dang, N., Kerr, E. O., Kirkland, K. T., Fields, S., & Kennedy, B. K. (2005) · Science · doi:10.1126/science.1115535 · Cited by 1,293
Autophagy Genes Are Essential for Dauer Development and Life-Span Extension in C. elegans
Meléndez, A., Tallóczy, Z., Seaman, M., Eskelinen, E.-L., Hall, D. H., & Levine, B. (2003) · Science · doi:10.1126/science.1087782 · Cited by 1,270
The coordinate regulation of the p53 and mTOR pathways in cells
Feng, Z., Zhang, H., Levine, A. J., & Jin, S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502857102 · Cited by 1,235
Hudson, C. C., Liu, M., Chiang, G. G., Otterness, D. M., Loomis, D. C., Kaper, F., Giaccia, A. J., & Abraham, R. T. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.20.7004-7014.2002 · Cited by 1,186
A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin Signaling
Knight, Z. A., Gonzalez, B., Feldman, M. E., Zunder, E. R., Goldenberg, D. D., Williams, O., Loewith, R., Stokoe, D., Balla, A., Toth, B., et al. (2006) · Cell · doi:10.1016/j.cell.2006.03.035 · Cited by 1,174
The TSC1-2 tumor suppressor controls insulin–PI3K signaling via regulation of IRS proteins
Harrington, L. S., Findlay, G. M., Gray, A., Tolkacheva, T., Wigfield, S., Rebholz, H., Barnett, J., Leslie, N. R., Cheng, S., Shepherd, P. R., et al. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200403069 · Cited by 1,123
Extension of Chronological Life Span in Yeast by Decreased TOR Pathway Signaling
Powers, R. W., Kaeberlein, M., Caldwell, S. D., Kennedy, B. K., & Fields, S. (2006) · Genes & Development · doi:10.1101/gad.1381406 · Cited by 982
Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR
Neshat, M. S., Mellinghoff, I. K., Tran, C., Stiles, B., Thomas, G., Petersen, R., Frost, P., Gibbons, J. J., Wu, H., & Sawyers, C. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171076798 · Cited by 969
Mammalian TOR: a homeostatic ATP sensor
Dennis, P. B., Jaeschke, A., Saitoh, M., Fowler, B., Kozma, S. C., & Thomas, G. (2001) · Science · doi:10.1126/science.1063518 · Cited by 962
Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy
Wendel, H.-G., Stanchina, E. D., Fridman, J. S., Malina, A., Ray, S., Kogan, S., Cordon-Cardo, C., Pelletier, J., & Lowe, S. W. (2004) · Nature · doi:10.1038/nature02369 · Cited by 951
NAVÉ, B. T., Ouwens, D. M., Withers, D. J., Alessi, D. R., & Shepherd, P. R. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3440427 · Cited by 932
Structure of the FKBP12-Rapamycin Complex Interacting with Binding Domain of Human FRAP
Choi, J., Chen, J., Schreiber, S. L., & Clardy, J. (1996) · Science · doi:10.1126/science.273.5272.239 · Cited by 929
Type 2 Diabetes-a Matter of ß-Cell Life and Death?
Rhodes, C. J. (2005) · Science · doi:10.1126/science.1104345 · Cited by 896
Hypertrophy of the Heart: A New Therapeutic Target?
Frey, N., Katus, H. A., Olson, E. N., & Hill, J. A. (2004) · Circulation · doi:10.1161/01.cir.0000120390.68287.bb · Cited by 851
Shillingford, J. M., Murcia, N. S., Larson, C. H., Low, S. H., Hedgepeth, R., Brown, N., Flask, C. A., Novick, A. C., Goldfarb, D. A., Kramer-Zucker, A., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509694103 · Cited by 808
Shah, O. J., Wang, Z., & Hunter, T. (2004) · Current Biology · doi:10.1016/j.cub.2004.08.026 · Cited by 798
Serruys, P. W., Kutryk, M. J. B., & Ong, A. T. L. (2006) · New England Journal of Medicine · doi:10.1056/nejmra051091 · Cited by 762
Pende, M., Um, S. H., Mieulet, V., Sticker, M., Goss, V. L., Mestan, J., Mueller, M., Fumagalli, S., Kozma, S. C., & Thomas, G. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.8.3112-3124.2004 · Cited by 742
Tang, S. J., Reis, G., Kang, H., Gingras, A.-C., Sonenberg, N., & Schuman, E. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012605299 · Cited by 734
Control of p70 S6 kinase by kinase activity of FRAP in vivo
Brown, E. J., Beal, P. A., Keith, C. T., Chen, J., Bum Shin, T., & Schreiber, S. L. (1995) · Nature · doi:10.1038/377441a0 · Cited by 705
The Mechanism of Action of Cyclosporin A and FK506
Ho, S., Clipstone, N., Timmermann, L., Northrop, J., Graef, I., Fiorentino, D., Nourse, J., & Crabtree, G. R. (1996) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1996.0140 · Cited by 677
Ribosomal S6 Kinase Signaling and the Control of Translation
Dufner, A., & Thomas, G. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4683 · Cited by 676
Rapamycin alleviates toxicity of different aggregate-prone proteins
Berger, Z., Ravikumar, B., Menzies, F. M., Oroz, L. G., Underwood, B. R., Pangalos, M. N., Schmitt, I., Wullner, U., Evert, B. O., O'Kane, C. J., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddi458 · Cited by 657
IMMUNOPHARMACOLOGY OF RAPAMYCIN
Abraham, R. T., & Wiederrecht, G. J. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.483 · Cited by 653
mTOR-targeted therapy of cancer with rapamycin derivatives
Vignot, S., Faivre, S., Aguirre, D., & Raymond, E. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi113 · Cited by 617
Jia, K., Chen, D., & Riddle, D. L. (2004) · Development · doi:10.1242/dev.01255 · Cited by 615
HEAT repeats in the Huntington's disease protein
Andrade, M. A., & Bork, P. (1995) · Nature Genetics · doi:10.1038/ng1095-115 · Cited by 597
A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma
Fan, Q.-W., Knight, Z. A., Goldenberg, D. D., Yu, W., Mostov, K. E., Stokoe, D., Shokat, K. M., & Weiss, W. A. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.03.029 · Cited by 585
Chen, J., Zheng, X. F., Brown, E. J., & Schreiber, S. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.4947 · Cited by 556
Self-citationTreins, C., Giorgetti-Peraldi, S., Murdaca, J., Semenza, G. L., & Van Obberghen, E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204152200 · Cited by 539
An expanding role for mTOR in cancer
Guertin, D. A., & Sabatini, D. M. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.06.007 · Cited by 523
PIK-Related Kinases: DNA Repair, Recombination, and Cell Cycle Checkpoints
Keith, C. T., & Schreiber, S. L. (1995) · Science · doi:10.1126/science.270.5233.50 · Cited by 518
McMullen, J. R., Sherwood, M. C., Tarnavski, O., Zhang, L., Dorfman, A. L., Shioi, T., & Izumo, S. (2004) · Circulation · doi:10.1161/01.cir.0000130641.08705.45 · Cited by 518
Rapamycin inhibits vascular smooth muscle cell migration.
Poon, M., Marx, S. O., Gallo, R., Badimon, J. J., Taubman, M. B., & Marks, A. R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119038 · Cited by 511
Raymond, E., Alexandre, J., Faivre, S., Vera, K., Materman, E., Boni, J., Leister, C., Korth-Bradley, J., Hanauske, A., & Armand, J.-P. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.116 · Cited by 499
Gangloff, Y.-G., Mueller, M., Dann, S. G., Svoboda, P., Sticker, M., Spetz, J.-F., Um, S. H., Brown, E. J., Cereghini, S., Thomas, G., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.21.9508-9516.2004 · Cited by 485
Hypoinsulinaemia, glucose intolerance and diminished β-cell size in S6K1-deficient mice
Pende, M., Kozma, S. C., Jaquet, M., Oorschot, V., Burcelin, R., Le Marchand-Brustel, Y., Klumperman, J., Thorens, B., & Thomas, G. (2000) · Nature · doi:10.1038/35050135 · Cited by 459
Kim, J. E., & Chen, J. (2004) · Diabetes · doi:10.2337/diabetes.53.11.2748 · Cited by 454
Targeting mTOR signaling for cancer therapy
Huang, S. (2003) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(03)00071-7 · Cited by 436
Yu, K., Toral-Barza, L., Discafani, C., Zhang, W. G., Skotnicki, J., Frost, P., & Gibbons, J. J. (2001) · Endocrine-related cancer · doi:10.1677/erc.0.0080249 · Cited by 420
Adipose tissue reduction in mice lacking the translational inhibitor 4E-BP1
Tsukiyama-Kohara, K., Poulin, F., Kohara, M., DeMaria, C. T., Cheng, A., Wu, Z., Gingras, A.-C., Katsume, A., Elchebly, M., Spiegelman, B. M., et al. (2001) · Nature Medicine · doi:10.1038/nm1001-1128 · Cited by 391
Hackstein, H., Taner, T., Zahorchak, A. F., Morelli, A. E., Logar, A. J., Gessner, A., & Thomson, A. W. (2003) · Blood · doi:10.1182/blood-2002-11-3370 · Cited by 381
Signaling by Target of Rapamycin Proteins in Cell Growth Control
Inoki, K., Ouyang, H., Li, Y., & Guan, K.-L. (2005) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.69.1.79-100.2005 · Cited by 330
Li, X., Alafuzoff, I., Soininen, H., Winblad, B., & Pei, J. (2005) · The FEBS Journal · doi:10.1111/j.1742-4658.2005.04833.x · Cited by 324
Bonafè, M., Barbieri, M., Marchegiani, F., Olivieri, F., Ragno, E., Giampieri, C., Mugianesi, E., Centurelli, M., Franceschi, C., & Paolisso, G. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021810 · Cited by 313
Zheng, X.-F., Fiorentino, D., Chen, J., Crabtree, G. R., & Schreiber, S. L. (1995) · Cell · doi:10.1016/0092-8674(95)90058-6 · Cited by 301
Self-citationMinireview: The Role of Oxidative Stress in Relation to Caloric Restriction and Longevity
Gredilla, R., & Barja, G. (2005) · Endocrinology · doi:10.1210/en.2005-0378 · Cited by 265
Murgia, M. G., Jordan, S., & Kahan, B. D. (1996) · Kidney International · doi:10.1038/ki.1996.28 · Cited by 261
SDZ RAD, A NEW RAPAMYCIN DERIVATIVE: Synergism with Cyclosporine
Schuurman, H.-J., Cottens, S., Fuchs, S., Joergensen, J., Meerloo, T., Sedrani, R., Tanner, M., Zenke, G., & Schuler, W. (1997) · Transplantation · doi:10.1097/00007890-199707150-00007 · Cited by 248
Teutonico, A., Schena, P. F., & Di Paolo, S. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005050487 · Cited by 239
Breese, C. R., Ingram, R. L., & Sonntag, W. E. (1991) · Journal of Gerontology · doi:10.1093/geronj/46.5.b180 · Cited by 236
Cortical Tuber Count: A Biomarker Indicating Neurologic Severity of Tuberous Sclerosis Complex
Goodman, M., Lamm, S. H., Engel, A., Shepherd, C. W., Houser, O. W., & Gomez, M. R. (1997) · Journal of Child Neurology · doi:10.1177/088307389701200203 · Cited by 234
Tripartite Regulation of Gln3p by TOR, Ure2p, and Phosphatases
Bertram, P. G., Choi, J. H., Carvalho, J., Ai, W., Zeng, C., Chan, T.-F., & Zheng, X. F. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004235200 · Cited by 231
Self-citationRapamycin inhibits clonal expansion and adipogenic differentiation of 3T3-L1 cells.
Yeh, W. C., Bierer, B. E., & McKnight, S. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.24.11086 · Cited by 227
Insulin-stimulated phosphorylation of lipin mediated by the mammalian target of rapamycin
Huffman, T. A., Mothe-Satney, I., & Lawrence, J. C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022634399 · Cited by 215
Sirolimus Does Not Exhibit Nephrotoxicity Compared to Cyclosporine in Renal Transplant Recipients
Morales, J. M., Wramner, L., Kreis, H., Durand, D., Campistol, J. M., Andres, A., Arenas, J., Nègre, E., Burke, J. T., & Groth, C. G. (2002) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2002.20507.x · Cited by 188
Chan, T.-F., Carvalho, J., Riles, L., & Zheng, X. F. S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240444197 · Cited by 171
Self-citationWoltman, A. M., de Fijter, J. W., Kamerling, S. W. A., van der Kooij, S. W., Paul, L., Daha, M. R., & van Kooten, C. (2001) · Blood · doi:10.1182/blood.v98.1.174 · Cited by 159
New developments in the neurobiology of the tuberous sclerosis complex
Crino, P. B., & Henske, E. P. (1999) · Neurology · doi:10.1212/wnl.53.7.1384 · Cited by 153
Regulation of adipocyte differentiation and insulin action with rapamycin
Cho, H. J., Park, J., Lee, H. W., Lee, Y. S., & Kim, J. B. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.07.050 · Cited by 151
Identification of TOR Signaling Complexes
Abraham, R. T. (2002) · Cell · doi:10.1016/s0092-8674(02)01009-7 · Cited by 150
Atomic structure of the rapamycin human immunophilin FKBP-12 complex
Duyne, G. D. V., Standaert, R. F., Schreiber, S. L., & Clardy, J. (1991) · Journal of the American Chemical Society · doi:10.1021/ja00019a057 · Cited by 150
Subfield History: Caloric Restriction, Slowing Aging, and Extending Life
Masoro, E. J. (2003) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2003.8.re2 · Cited by 149
Briaud, I., Dickson, L. M., Lingohr, M. K., McCuaig, J. F., Lawrence, J. C., & Rhodes, C. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m412179200 · Cited by 141
Regulation of Subtelomeric Silencing during Stress Response
Ai, W., Bertram, P. G., Tsang, C. K., Chan, T., & Zheng, X. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00695-0 · Cited by 134
Self-citationMetabolic and Autocrine Regulation of the Mammalian Target of Rapamycin by Pancreatic β-Cells
McDaniel, M. L., Marshall, C. A., Pappan, K. L., & Kwon, G. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2877 · Cited by 134
PI3-kinase and TOR: PIKTORing cell growth
Richardson, C. J., Schalm, S. S., & Blenis, J. (2004) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2003.12.023 · Cited by 133
Fox, H. L., Kimball, S. R., Jefferson, L. S., & Lynch, C. J. (1998) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1998.274.1.c206 · Cited by 125
ATOMIC STRUCTURE OF THE RAPAMYCIN HUMAN IMMUNOPHILIN FKBP-12 COMPLEX
Duyne, G. D. V., Standaert, R. F., Schreiber, S. L., & Clardy, J. (1992) · Worldwide Protein Data Bank · doi:10.2210/pdb1fkb/pdb · Cited by 122
de Nobel, H., Lawrie, L. C., Brul, S., Klis, F. M., Davis, M. A. F., Alloush, H. M., & Coote, P. J. (2001) · Yeast · doi:10.1002/yea.793 · Cited by 119
Drosophila Melted Modulates FOXO and TOR Activity
Teleman, A. A., Chen, Y., & Cohen, S. M. (2005) · Developmental Cell · doi:10.1016/j.devcel.2005.07.004 · Cited by 116
Asaki, C., Usuda, N., Nakazawa, A., Kametani, K., & Suzuki, T. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02523-x · Cited by 76
McMahon, L. P., Yue, W., Santen, R. J., & Lawrence, J. C. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0305 · Cited by 53
New Rapamycin Derivatives by Precursor‐Directed Biosynthesis
Lowden, P. A. S., Böhm, G. A., Metcalfe, S. M., Staunton, J., & Leadlay, P. F. (2004) · ChemBioChem · doi:10.1002/cbic.200300758 · Cited by 51
Production of Novel Rapamycin Analogs by Precursor-Directed Biosynthesis
Ritacco, F. V., Graziani, E. I., Summers, M. Y., Zabriskie, T. M., Yu, K., Bernan, V. S., Carter, G. T., & Greenstein, M. D. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.4.1971-1976.2005 · Cited by 44
Gregory, M. A., Gaisser, S., Lill, R. E., Hong, H., Sheridan, R., Wilkinson, B. M., Petković, H., Weston, A. J., Carletti, I., Lee, H., et al. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200453764 · Cited by 43
Design, synthesis and X-ray crystallographic studies of novel FKBP-12 ligands
Babine, R. E., Bleckman, T. M., Kissinger, C. R., Showalter, R. E., Pelletier, L. A., Lewis, C. T., Tucker, K. D., Moomaw, E. W., Parge, H. E., & Villafranca, J. E. (1995) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/0960-894x(95)00290-a · Cited by 42
Kidney transplantation without calcineurin inhibitors using sirolimus
Stegall, M. D., Larson, T. S., Prieto, M., Gloor, J. M., Textor, S. C., Nyberg, S. L., Sterioff, S., Ishitani, M., Griffin, M. D., Kremers, W. K., et al. (2003) · Transplantation Proceedings · doi:10.1016/s0041-1345(03)00226-4 · Cited by 34
Xenobiotic immunosuppressive agents: therapeutic effects in animal models of autoimmune diseases
Burkhardt, H., & Kalden, J. R. (1997) · Rheumatology International · doi:10.1007/s002960050014 · Cited by 30
Emerging strategies for the clinical application of rapamycin
Kahan, B. D. (1998) · Clinical Biochemistry · doi:10.1016/s0009-9120(98)00044-7 · Cited by 12
Cited by
Endoplasmic reticulum stress and the inflammatory basis of metabolic disease
Hotamisligil, G. S. (2010) · Cell · doi:10.1016/j.cell.2010.02.034 · Cited by 2,802
Kisspeptins and Reproduction: Physiological Roles and Regulatory Mechanisms
Pinilla, L., Aguilar, E., Dieguez, C., Millar, R. P., & Tena-Sempere, M. (2012) · Physiological Reviews · doi:10.1152/physrev.00037.2010 · Cited by 801
Speakman, J. R., & Mitchell, S. E. (2011) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.07.001 · Cited by 749
Natural Products as Leads to Potential Drugs: An Old Process or the New Hope for Drug Discovery?
Newman, D. J. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm0704090 · Cited by 716
Bentzinger, C. F., Romanino, K., Cloëtta, D., Lin, S., Mascarenhas, J. B., Oliveri, F., Xia, J., Casanova, E., Costa, C. F., Brink, M., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.10.002 · Cited by 640
Metadata
- Authors
- Tsang, C. K., Qi, H., Liu, L. F., & Zheng, X. F. S.
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2007-02
- Volume
- 12
- Issue
- 3-4
- Pages
- 112-124
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W2035029345
- Cited by
- 406
- References
- 98
- FWCI
- 9.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.